NCT06919900 Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
| NCT ID | NCT06919900 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgia State University |
| Condition | Multiple Sclerosis (Relapsing Remitting) |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2026-01 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2026-01 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary purpose of this interventional study is to examine the overall motor learning capacity from exposure to repeated perturbations among ambulatory people with multiple sclerosis (MS). This project will advance our understanding of learning new motor skills from exposure to external perturbations. If it is proven that people with MS can learn motor skills from perturbation training, the findings from this study will pave a theoretical foundation for applying perturbation training as a promising fall prevention intervention for people with MS.
Eligibility Criteria
Inclusion Criteria: 1. Clinically confirmed multiple sclerosis 2. At least 45 years old 3. Able to walk independently at least 25 feet 4. Able to stand independently for at least 30 seconds 5. Patient Determined Disability Steps score between 0 and 4 6. Free from pregnancy 7. Montreal Cognitive Assessment score of 23 or higher Exclusion Criteria: 1. Previous experience with perturbation training 2. T-score from the dual x-ray absorptiometry (DXA) scan of less than -2.5 3. Coexisting psychiatric disorders or other neurological conditions, severe medical illness, or cardiovascular diseases 4. Participants have had a relapse in the past 8 weeks
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06919900 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 89 Years, studying Multiple Sclerosis (Relapsing Remitting). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06919900 currently recruiting?
Yes, NCT06919900 is actively recruiting participants. Contact the research team at fyang@gsu.edu for enrollment information.
Where is the NCT06919900 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT06919900 clinical trial?
NCT06919900 is sponsored by Georgia State University. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.